Skip to main content
. 2020 Mar 11;222(6):948–956. doi: 10.1093/infdis/jiaa099

Figure 4.

Figure 4.

Modeled eradication of human papillomavirus (HPV) types 16 [■], 18 [■], and oncogenic HPV types with moderate (31 of 33) [■] or fast (35) [■] clearance rates by vaccine efficacy ([VE] 95%/80%/50%), with 50% girls-only vaccination coverage, with 25% boys and 50% girls vaccination coverage, and with 50% gender-neutral vaccination coverage.